Tuberculin skin test reactivity of health care students in a country with a low prevalence of tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 10, 2010, Pages 1272-1279

  Fjällbrant, Harald ^a   Rutqvist, A ^a   Widstrom O ^b   Zetterberg, G ^b   Ridell, M ^a   Larsson, L O ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bacille Calmette Gu Rin vaccine; Latent tuberculosis infection; Non tuberculous mycobacteria; Occupational diseases; Tuberculin skin test

Indexed keywords

BCG VACCINE;

ADULT; AGE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; FEMALE; GEOGRAPHIC ORIGIN; HEALTH SERVICE; HUMAN; HUMAN EXPERIMENT; IMMUNOREACTIVITY; MALE; MYCOBACTERIUM AVIUM; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; ADULT; AGE FACTORS; BCG VACCINE; FEMALE; HEALTH PERSONNEL; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MYCOBACTERIUM; PREDICTIVE VALUE OF TESTS; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEX FACTORS; STUDENTS; SWEDEN; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 77957099390     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
2. Watkins R E, Brennan R, Plant A J. Tuberculin reactivity and the risk of tuberculosis: a review. Int J Tuberc Lung Dis 2000; 4: 895-903.
3. von Reyn C F, Barber T W, Arbeit R D, et al. Evidence of previous infection with Mycobacterium avium - Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis 1993; 168: 1553-1558.
4. Larsson L O, Bentzon M W, Lind A, et al. Sensitivity to sensitins and tuberculin in Swedish children. Part 5. A study of school children in an inland rural area. Tubercle Lung Dis 1993; 74: 371-376.
5. Fine P E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346: 1339-1345.
6. Lind A, Larsson L O, Bentzon M W, et al. Sensitivity to sensitins and tuberculin in Swedish children. I. A study of schoolchildren in an urban area. Tubercle 1991; 72: 29-36.
7. Rieder H L. Epidemiologic basis of tuberculosis control. Paris, France: International Union Against Tuberculosis and Lung Disease, 1999.
8. Seidler A, Nienhaus A, Diel R. Review of epidemiological studies on the occupational risk of tuberculosis in low-incidence areas. Respiration 2005; 72: 431-446. (Pubitemid 41160180)
9. Arnadottir T, Rieder H L, Trebucq A, Waaler H T. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tubercle Lung Dis 1996; 77 (Suppl 1): 1-19. (Pubitemid 26285466)
10. Berkel G M, Cobelens F G, de Vries G, Draayer-Jansen I W, Borgdorff M W. Tuberculin skin test: estimation of positive and negative predictive values from routine data. Int J Tuberc Lung Dis 2005; 9: 310-316.
11. Bruins J, Gribnau J H, Bwire R. Investigation into typical and atypical tuberculin sensitivity in the Royal Netherlands Army, resulting in a more rational indication for isoniazid prophylaxis. Tubercle Lung Dis 1995; 76: 540-544. (Pubitemid 26008711)
12. von Reyn C F, Horsburgh C R, Olivier K N, et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001; 5: 1122-1128.
13. Palmer C E, Long M W. Effects of infection with atypical m ycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis 1966; 94: 553-568.
14. Palmer C E, Edwards L B. Identifying the tuberculous infected. The dual-test technique. JAMA 1968; 205: 167-169.
15. Hart P D, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J 1977; 2: 293-295.
16. Stead W W. Management of health care workers after inadvertent exposure to tuberculosis: a guide for the use of preventive therapy. Ann Intern Med 1995; 122: 906-912.
17. Poulsen A. Some clinical features of tuberculosis. Acta Tuberc Scand 1957; 33: 37-92.
18. Brewer T F, Colditz G A. Bacille Calmette-Guerin vaccination for the prevention of tuberculosis in health care workers. Clin Infect Dis 1995; 20: 136-142.
19. Royal College of Physicians. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London, UK: National Institute for Health and Clinical Excellence, 2006. http://guidance.nice.org.uk/CG33 Accessed March 2010.
20. Kamper-Jørgensen Z, Lillebaek T, Bengaard Andersen A. Occupational tuberculosis following extremely short exposure. Clin Respir J 2009; 3: 55-57.
21. Hart P, Sutherland I, Thomas J. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and technical variations in the vaccines. Tubercle 1967; 48: 201-210.
22. Soborg B, Andersen A B, Larsen H K, et al. Detecting a low prevalence of latent tuberculosis among health care workers in Denmark detected by M. tuberculosis specific IFN-gamma whole-blood test. Scand J Infect Dis 2007; 39: 554-559.
23. Tissot F, Zanetti G, Francioli P, Zellweger J P, Zysset F. Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis 2005; 40: 211-217.
24. Larsson L O, Magnusson M, Skoogh B E, Lind A. Sensitivity to sensitins and tuberculin in Swedish children. IV. The influence of BCG-vaccination. Eur Respir J 1992; 5: 584-586.
25. Joos T J, Miller W C, Murdoch D M. Tuberculin reactivity in bacille Calmette-Guerin vaccinated populations: a compilation of international data. Int J Tuberc Lung Dis 2006; 10: 883-891.
26. Miret-Cuadras P, Pina-Gutierrez J M, Juncosa S. Tuberculin reactivity in bacillus Calmette-Guerin vaccinated subjects. Tubercle Lung Dis 1996; 77: 52-58. (Pubitemid 26066611)
27. Schwartzman K, Loo V, Pasztor J, Menzies D. Tuberculosis infection among health care workers in Montreal. Am J Respir Crit Care Med 1996; 154: 1006-1012.
28. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and nontuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1192-1204.
29. Jentoft H F, Omenaas E, Eide G E, Gulsvik A. Tuberculin reactivity: prevalence and predictors in BCG-vaccinated young Norwegian adults. Respir Med 2002; 96: 1033-1039. (Pubitemid 35386120)
30. Fjällbrant H, Ridell M, Larsson L O. BCG scar and tuberculin reactivity in children and adults. Scand J Infect Dis 2008; 40: 387-392. (Pubitemid 351566565)
31. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293: 2746-2755.
32. al-Kassimi F A, Abdullah A K, al-Orainey I O, et al. The signifi cance of positive Mantoux reactions in BCG-vaccinated children. Tubercle 1991; 72: 101-104.
33. Reed C, von Reyn C F, Chamblee S, et al. Environmental risk factors for infection with Mycobacterium avium complex. Am J Epidemiol 2006; 164: 32-40.
34. Larsson L O, Skoogh B E, Bentzon M W, et al. Sensitivity to sensitins and tuberculin in Swedish children. II. A study of preschool children. Tubercle 1991; 72: 37-42.
35. Menzies R, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis 1992; 146: 752-756.
36. Trump D H, Hyams K C, Cross E R, Struewing J P. Tuberculosis infection among young adults entering the US Navy in 1990. Arch Intern Med 1993; 153: 211-216.
37. Dolin P. Tuberculosis epidemiology from a gender perspective. In: Diwan V K, Thorson A, Winkvist A, eds. Gender and tuberculosis: an international research workshop. Report from the workshop at the Nordic School of Public Health, Göteborg, May 24-26, 1998. Göteborg, Sweden: Nordic School of Public Health, 1998: pp 29-40.